Cleveland Clinic Abu Dhabi delivers first infusion therapy for Parkinson's in region

17 June 2025 11:31
ABU DHABI (WAM) Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion therapy, a cutting-edge therapeutic treatment for advanced Parkinson's disease, making it the first hospital in the GCC region to offer this innovative therapy.The therapy offers a groundbreaking alternative for patients who are not candidates for DBS or prefer a non-invasive option.Notably, all patients in the advanced stages of Parkinson's are eligible for it. It delivers a continuous subcutaneous infusion of levodopa-carbidopa—the gold-standard medication for Parkinson's—through a compact pump connected to the skin. Unlike oral medications, which can lead to fluctuating absorption and inconsistent symptom control, this approach provides a steady, around-the-clock infusion, ensuring more stable symptom management.Additionally, post-treatment follow-ups are significantly reduced to once every six months, compared to the frequent monitoring required after DBS surgery, making it a more convenient long-term option for patients.Supported by an exceptional team of Parkinson's disease specialists providing 24/7 care, alongside a dedicated rehabilitation team and other medical professionals, Cleveland Clinic Abu Dhabi ensures patients receive the highest level of comprehensive, patient-centred care.Commenting on bringing advanced and tailored treatment solutions to the region, Dr. Georges-Pascal Haber, the CEO of Cleveland Clinic Abu Dhabi, said, 'The introduction of continuous therapy in the UAE and GCC represents a critical advancement in how we approach patient care and outcomes in the region. As neurodegenerative diseases become more prevalent, patients are increasingly in need of personalised, innovative solutions.'Highlighting the impact of the therapy, Dr. Shivam Om Mittal, Staff Physician, Neurological Institute at Cleveland Clinic Abu Dhabi, who led the treatment, said, 'We are proud to be the first in the region to offer this groundbreaking therapy so soon after its global introduction. At Cleveland Clinic Abu Dhabi, we provide a full spectrum of advanced Parkinson's treatments—including oral medication, deep brain stimulation (DBS), and now this treatment, ensuring each patient receives a personalised care plan. Additionally, our exceptional team of Parkinson's disease specialists, supported by a dedicated rehabilitation team and other medical professionals, ensures 24/7 care and comprehensive support for our patients at every stage of their journey.'The infusion system functions much like an insulin pump, with a compact, phone-sized device connected to a fine tube placed on the skin. It delivers a continuous infusion of Parkinson's medication throughout the day and night, maintaining stable drug levels and significantly reducing motor fluctuations and dyskinesias.This innovation is transforming how we manage advanced Parkinson's disease, offering patients greater stability, independence, and an improved quality of life. Additionally, its straightforward design makes it easy to implement, providing a seamless transition for both patients and caregivers.With Parkinson's disease being the fastest-growing neurodegenerative condition worldwide—expected to double by 2040—the need for innovative, effective treatments has never been more urgent. Currently, 1% of individuals over 60 years old are affected globally, with an increasing number of young-onset cases under 50 being diagnosed.Since its introduction in 2019 by Cleveland Clinic Abu Dhabi, deep brain stimulation (DBS) surgery has been the leading advanced treatment for Parkinson's in the UAE. The hospital has now successfully performed over 100 surgeries.Cleveland Clinic Abu Dhabi, through the pioneering introduction of continuous infusion therapy in the GCC, is leading the charge in neurological care.This marks a significant step forward in the UAE's ambition to become a global hub for medical innovation.
With its multidisciplinary approach to patient care, where neurology, surgery, rehabilitation, and other specialities collaborate seamlessly, it continues to set new standards in advancing treatment options that transform patient outcomes and improve lives across the region.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Al Etihad

6 days ago

• Al Etihad

Cleveland Clinic Abu Dhabi delivers first infusion therapy for Parkinson's in region

17 June 2025 11:31 ABU DHABI (WAM) Cleveland Clinic Abu Dhabi, part of the M42 group, has successfully introduced continuous infusion therapy, a cutting-edge therapeutic treatment for advanced Parkinson's disease, making it the first hospital in the GCC region to offer this innovative therapy offers a groundbreaking alternative for patients who are not candidates for DBS or prefer a non-invasive all patients in the advanced stages of Parkinson's are eligible for it. It delivers a continuous subcutaneous infusion of levodopa-carbidopa—the gold-standard medication for Parkinson's—through a compact pump connected to the skin. Unlike oral medications, which can lead to fluctuating absorption and inconsistent symptom control, this approach provides a steady, around-the-clock infusion, ensuring more stable symptom post-treatment follow-ups are significantly reduced to once every six months, compared to the frequent monitoring required after DBS surgery, making it a more convenient long-term option for by an exceptional team of Parkinson's disease specialists providing 24/7 care, alongside a dedicated rehabilitation team and other medical professionals, Cleveland Clinic Abu Dhabi ensures patients receive the highest level of comprehensive, patient-centred on bringing advanced and tailored treatment solutions to the region, Dr. Georges-Pascal Haber, the CEO of Cleveland Clinic Abu Dhabi, said, 'The introduction of continuous therapy in the UAE and GCC represents a critical advancement in how we approach patient care and outcomes in the region. As neurodegenerative diseases become more prevalent, patients are increasingly in need of personalised, innovative solutions.'Highlighting the impact of the therapy, Dr. Shivam Om Mittal, Staff Physician, Neurological Institute at Cleveland Clinic Abu Dhabi, who led the treatment, said, 'We are proud to be the first in the region to offer this groundbreaking therapy so soon after its global introduction. At Cleveland Clinic Abu Dhabi, we provide a full spectrum of advanced Parkinson's treatments—including oral medication, deep brain stimulation (DBS), and now this treatment, ensuring each patient receives a personalised care plan. Additionally, our exceptional team of Parkinson's disease specialists, supported by a dedicated rehabilitation team and other medical professionals, ensures 24/7 care and comprehensive support for our patients at every stage of their journey.'The infusion system functions much like an insulin pump, with a compact, phone-sized device connected to a fine tube placed on the skin. It delivers a continuous infusion of Parkinson's medication throughout the day and night, maintaining stable drug levels and significantly reducing motor fluctuations and innovation is transforming how we manage advanced Parkinson's disease, offering patients greater stability, independence, and an improved quality of life. Additionally, its straightforward design makes it easy to implement, providing a seamless transition for both patients and Parkinson's disease being the fastest-growing neurodegenerative condition worldwide—expected to double by 2040—the need for innovative, effective treatments has never been more urgent. Currently, 1% of individuals over 60 years old are affected globally, with an increasing number of young-onset cases under 50 being its introduction in 2019 by Cleveland Clinic Abu Dhabi, deep brain stimulation (DBS) surgery has been the leading advanced treatment for Parkinson's in the UAE. The hospital has now successfully performed over 100 Clinic Abu Dhabi, through the pioneering introduction of continuous infusion therapy in the GCC, is leading the charge in neurological marks a significant step forward in the UAE's ambition to become a global hub for medical innovation. With its multidisciplinary approach to patient care, where neurology, surgery, rehabilitation, and other specialities collaborate seamlessly, it continues to set new standards in advancing treatment options that transform patient outcomes and improve lives across the region.

TECHx

12-06-2025

• TECHx

King Faisal Hospital Reveals AI Brain Implant Breakthrough

Home » Middle East » King Faisal Hospital Reveals AI Brain Implant Breakthrough King Faisal Specialist Hospital & Research Centre (KFSHRC) has announced a major medical milestone. It has become the first institution in the Middle East to implant an AI-powered brain-sensing device. The technology is designed to treat complex neurological disorders. According to the hospital, the breakthrough marks the start of a new era in neuromodulation therapy. The device offers real-time, adaptive treatment for patients with conditions such as Parkinson's disease, epilepsy, and other movement disorders. KFSHRC revealed that the device uses artificial intelligence to monitor brain activity continuously. It identifies abnormal signals and sends precise electrical impulses to restore balance. This closed-loop system allows real-time adjustments based on the brain's activity. As a result, patients receive personalized therapy and consistent symptom control throughout the day. The hospital reported that the procedure is minimally invasive. It typically takes between three to five hours to complete. The new device may reduce reliance on medication by up to 50%. It also aims to improve patients' autonomy and quality of life. KFSHRC noted that patients show rapid recovery after surgery. Many report improved symptom control within weeks. This development highlights the leadership of KFSHRC's Neuroscience Centre of Excellence. The center provides multidisciplinary care for adult and paediatric cases. It leads in deep brain stimulation for movement disorders and stereotactic EEG for epilepsy. It also pioneers AI-based diagnostics for cognitive conditions and autism. The hospital emphasized its commitment to innovation and patient-centered care. It aims to set new standards in precision brain health. Recently, KFSHRC was ranked first in the Middle East and Africa and 15th globally among the world's top 250 academic medical centres. The 2025 Brand Finance report also recognized it as the most valuable healthcare brand in the region. In addition, Newsweek included KFSHRC in its 2025 list of the World's Best Smart Hospitals.

Gulf Today

11-06-2025

• Gulf Today

UAE performs first robotic surgery with HIPEC

Cleveland Clinic Abu Dhabi has successfully performed the UAE's first robotic cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) to treat a rare appendiceal tumour, in a medical milestone that reinforces Abu Dhabi's position as a global destination for innovative healthcare. The complex procedure, performed on a 48-year-old patient, involved the removal of multiple internal organs to prevent the spread of the tumour in her abdomen. This groundbreaking procedure was led by Dr Yasir Akmal, Staff Physician in the Digestive Disease Institute at Cleveland Clinic Abu Dhabi and an American Fellowship-trained surgical oncologist, and a multi-disciplinary team. Appendiceal tumours account for less than 1 per cent of malignancies worldwide and are found in approximately 1.4 per cent of patients who undergo an appendectomy. The patient initially presented symptoms resembling appendicitis, leading to the removal of her appendix. However, during the procedure, her surgeon discovered gelatinous deposits, a jelly-like substance, in the abdominal cavity. A subsequent pathology report confirmed the presence of a rare low-grade mucinous neoplasm, a tumour that, if untreated, could spread throughout the abdomen and result in a condition known as pseudomyxoma peritonei or 'jelly belly.' Dr Georges-Pascal Haber, Chief Executive Officer of Cleveland Clinic Abu Dhabi, said, 'We are pushing the boundaries of robotic surgery and are proud to have used such an advanced technology for a complex procedure like Paola's. Cleveland Clinic Abu Dhabi is a leader in surgical innovation, continuously refining minimally invasive techniques to improve outcomes and enhance quality of life.' Following the tumour removal, HIPEC treatment (Hyperthermic Intraperitoneal Chemotherapy) was administered- a technique where heated chemotherapy (42 degrees Celsius) is circulated within the abdominal cavity for 90 minutes to eliminate any residual cancer cells. Highlighting both the preventive and curative nature of the surgery, Dr Akmal said that the patient's condition was diagnosed at an advanced but treatable stage, and thanks to the timely intervention of the multidisciplinary team, supported by specialised AI-driven diagnostic tools, the team was able to navigate the process of eliminating the cancer cells in her body with precision. WAM